These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 6174200)

  • 1. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
    Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
    Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
    Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
    Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
    Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
    Meyers PA; Gorlick R; Heller G; Casper E; Lane J; Huvos AG; Healey JH
    J Clin Oncol; 1998 Jul; 16(7):2452-8. PubMed ID: 9667263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
    Winkler K; Beron G; Delling G; Heise U; Kabisch H; Purfürst C; Berger J; Ritter J; Jürgens H; Gerein V
    J Clin Oncol; 1988 Feb; 6(2):329-37. PubMed ID: 2448428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors.
    Rosen G; Caparros B; Groshen S; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Huvos AG
    Cancer Invest; 1984; 2(3):181-92. PubMed ID: 6203625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
    Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
    J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
    Provisor AJ; Ettinger LJ; Nachman JB; Krailo MD; Makley JT; Yunis EJ; Huvos AG; Betcher DL; Baum ES; Kisker CT; Miser JS
    J Clin Oncol; 1997 Jan; 15(1):76-84. PubMed ID: 8996127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
    Winkler K; Beron G; Kotz R; Salzer-Kuntschik M; Beck J; Beck W; Brandeis W; Ebell W; Erttmann R; Göbel U; Havers W; Henze G; Hinderfield L; Höcker P; Jobke A; Jürgens H; Kabisch H; Landbeck G; Preusser P; Prindull G; Ramach W; Ritter J; Sekera J; Treuner J; Wüst G
    J Cancer Res Clin Oncol; 1983; 106 Suppl():1-7. PubMed ID: 6193123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
    Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
    Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alternative chemotherapy of malignant bone neoplasms in children].
    Jurczyk-Procyk S; Perek D
    Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma.
    Mosende C; Gutierrez M; Caparros B; Rosen G
    Cancer; 1977 Dec; 40(6):2779-86. PubMed ID: 73409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
    Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
    Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
    Saeter G; Alvegård TA; Elomaa I; Stenwig AE; Holmström T; Solheim OP
    J Clin Oncol; 1991 Oct; 9(10):1766-75. PubMed ID: 1717666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
    Marroum MC; Huvos AG; Rosen G
    Oncology; 1977; 34(6):273-80. PubMed ID: 304199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.
    Rosen G; Marcove RC; Huvos AG; Caparros BI; Lane JM; Nirenberg A; Cacavio A; Groshen S
    J Cancer Res Clin Oncol; 1983; 106 Suppl():55-67. PubMed ID: 6604058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.